Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) Enterprise Value (2020 - 2025)

Historic Enterprise Value for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to -$294.3 million.

  • PROCEPT BioRobotics' Enterprise Value fell 4956.19% to -$294.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$294.3 million, marking a year-over-year decrease of 4956.19%. This contributed to the annual value of -$333.7 million for FY2024, which is 2974.2% down from last year.
  • PROCEPT BioRobotics' Enterprise Value amounted to -$294.3 million in Q3 2025, which was down 4956.19% from -$302.7 million recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' Enterprise Value registered a high of -$86.1 million during Q1 2021, and its lowest value of -$333.7 million during Q4 2024.
  • Over the past 5 years, PROCEPT BioRobotics' median Enterprise Value value was -$257.2 million (recorded in 2023), while the average stood at -$245.1 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first tumbled by 23011.45% in 2022, then surged by 4423.1% in 2023.
  • PROCEPT BioRobotics' Enterprise Value (Quarter) stood at -$304.3 million in 2021, then rose by 26.84% to -$222.6 million in 2022, then decreased by 15.53% to -$257.2 million in 2023, then dropped by 29.74% to -$333.7 million in 2024, then increased by 11.82% to -$294.3 million in 2025.
  • Its Enterprise Value was -$294.3 million in Q3 2025, compared to -$302.7 million in Q2 2025 and -$316.2 million in Q1 2025.